HXE Powder white crystalline hydroxetamine arylcyclohexylamine research material
HXE Powder Price range: € 54,00 through € 340,00
Back to products
3-Me-PCPy Powder white crystalline arylcyclohexylamine research material
3-Me-PCPy Powder Price range: € 60,00 through € 125,00

DeschcloroKetamine (DCK) Pellets – 20mg

Price range: € 19,75 through € 537,50

Deschloroketamine (DCK) Pellets 20mg are described as compressed research pellets with a nominal label claim of 20 mg deschloroketamine hydrochloride per unit.

Deschloroketamine, also called DCK or 2′-Oxo-PCM, is an arylcyclohexylamine structurally related to ketamine.

The source describes resealable packaging, a typical ingredient-purity specification of at least 98% by HPLC, and storage at approximately 2–8°C.

It also claims batch traceability, third-party analytical testing, and pellet-weight consistency within ±2%.

These claims have not been independently verified.

The supplied molecular specifications require correction. The formula C15H21NO does not correspond to the commonly described deschloroketamine structure. The reported hydrochloride molecular weight of 267.80 g/mol is also inconsistent with the commonly described DCK hydrochloride composition.

No batch-specific Certificate of Analysis, finished-pellet assay, or content-uniformity dataset was supplied.

The nominal 20 mg label claim therefore does not establish verified ingredient content in each pellet.

Deschloroketamine presents potentially serious dissociative and neurological hazards.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-P-12421 Category:
Description

Deschloroketamine (DCK) Pellets 20mg – Research Material Information

Deschloroketamine (DCK) Pellets 20mg – Product Overview

The supplied product is described as compressed research pellets containing deschloroketamine hydrochloride.

Each pellet carries a nominal label claim of 20 mg.

The source identifies the material as intended for laboratory contexts involving chemical characterization, chromatographic analysis, and forensic identification.

No finished-pellet assay or independent content-uniformity report was provided.

The stated content is therefore a nominal specification rather than a verified measurement for each unit.

The source also contains conflicting molecular specifications that should be resolved before publication.

Chemical Identity & Classification

Deschloroketamine is an arylcyclohexylamine structurally related to ketamine.

It is commonly described as 2-(methylamino)-2-phenylcyclohexan-1-one.

The supplied specifications are:

  • Compound designation: Deschloroketamine
  • Synonyms: DCK, DXE, 2′-Oxo-PCM
  • Reported CAS number: 4631-27-0
  • Reported chemical form: Hydrochloride
  • Supplied formula: C15H21NO-HCl
  • Supplied molecular weight: 267.80 g/mol
  • Product form: Compressed pellets
  • Nominal content: 20 mg per pellet

The supplied molecular formula is not consistent with the commonly described DCK structure.

Neutral deschloroketamine is generally represented by C13H17NO, with a molecular weight of approximately 203.28 g/mol.

The corresponding hydrochloride composition is C13H18ClNO, with a molecular weight of approximately 239.74 g/mol.

The supplied CAS number also requires confirmation for the specified chemical form.

Public chemical-reference information can be reviewed through PubChem.

Chemical & Physical Characteristics

The source describes a compressed pellet presentation.

No independently verified pellet dimensions, color specifications, excipient composition, hardness measurements, or disintegration data were supplied.

The brief reports solubility of approximately 10–15 mg/mL in DMSO or methanol.

No supporting solubility measurements, experimental conditions, or analytical report was provided.

The source also refers to thermal stability and quantitative recovery under analytical conditions.

These properties may depend on the chemical form and finished-pellet formulation.

No validated stability, dissolution, or quantitative-recovery dataset was supplied.

Purity & Analytical Verification

The source reports typical ingredient purity of at least 98% by HPLC.

It also claims identity confirmation using HPLC, mass spectrometry, and NMR spectroscopy.

No chromatograms, spectra, impurity profiles, or batch-specific Certificate of Analysis were provided.

The reported purity therefore remains unverified.

The source describes a protonated molecular ion at nominal m/z 244.

This value does not correspond to the expected protonated molecular ion of neutral deschloroketamine, which is approximately m/z 204.1383.

The supplied mass spectrometry value should not be presented as verified DCK identity evidence.

Ingredient purity and finished-pellet content are separate measurements.

A high-purity ingredient does not establish that each compressed pellet contains exactly 20 mg of the reported compound.

Quality Control & Batch Integrity

The brief claims batch traceability, third-party testing, residual-solvent analysis, homogeneity assessment, and content-uniformity verification.

It also reports pellet-weight consistency within ±2%.

No supporting batch records or independent analytical reports were supplied.

Pellet-weight variation describes differences in total pellet mass.

It does not independently establish ingredient-content uniformity.

The source also claims consistent dissolution performance.

No validated dissolution measurements were provided.

These quality-control statements remain unverified supplier claims.

Safety, Handling & Laboratory Precautions

Deschloroketamine is associated with dissociative psychoactive activity.

Potential hazards include impaired coordination, confusion, altered perception, agitation, and cardiovascular complications.

Its toxicological profile remains incompletely characterized.

Institutional safety procedures should address restricted access, appropriate protective equipment, contamination prevention, accidental-exposure response, secure custody, and chemical-waste management.

No verified product-specific Safety Data Sheet was supplied.

The pellet format does not establish suitability for human or veterinary administration.

Packaging, Labeling & Storage

The source describes compressed pellets supplied in resealable packaging.

It recommends storage at approximately 2–8°C, protected from light and moisture.

No validated product-specific stability study was supplied to establish this temperature range as necessary or sufficient.

No verified shelf life, packaging-barrier performance, or finished-product stability dataset was provided.

Labels should accurately distinguish the chemical form, nominal content, and independently verified batch specifications.

Intended Research Use & Market Positioning

The source identifies analytical laboratory contexts involving arylcyclohexylamine characterization, chromatographic profiling, and forensic chemical identification.

No certified reference-material status or validated quantitative calibration performance has been established.

The supplied Raw Lab Chems catalog references are:

These links concern opioid-related compounds, not deschloroketamine.

They should not be described as chemically equivalent or interchangeable with DCK.

Ordering, Availability & Fulfillment

The source claims international shipping, tracking, customs documentation, protective packaging, and compliance with IATA and DOT requirements.

No current inventory record, transport classification, carrier authorization, or supporting shipping documentation was supplied.

These claims cannot be independently confirmed.

Research-only labeling does not automatically exempt a psychoactive chemical from controlled-substance legislation, analogue laws, or import restrictions.

Legal authorization and transport eligibility depend on the applicable jurisdiction and transaction.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Deschloroketamine is a psychoactive arylcyclohexylamine-related substance that may be subject to controlled-substance, analogue, chemical-safety, import, or export restrictions.

Institutions are responsible for verifying applicable legal requirements and maintaining appropriate authorization, laboratory controls, and secure custody.

No therapeutic approval, consumer-use authorization, or certified reference-material status is implied.

The chemical identity, salt form, and molecular specifications should be resolved before publication as definitive product information.

Additional information
Quantity (pellets)

5

,

10

,

25

,

50

,

100

,

250

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “DeschcloroKetamine (DCK) Pellets – 20mg”
Shipping & Delivery